Danielle Murphy

4.1k total citations · 2 hit papers
23 papers, 2.5k citations indexed

About

Danielle Murphy is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Danielle Murphy has authored 23 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 13 papers in Oncology and 11 papers in Molecular Biology. Recurrent topics in Danielle Murphy's work include Lung Cancer Treatments and Mutations (11 papers), Colorectal Cancer Treatments and Studies (7 papers) and Angiogenesis and VEGF in Cancer (4 papers). Danielle Murphy is often cited by papers focused on Lung Cancer Treatments and Mutations (11 papers), Colorectal Cancer Treatments and Studies (7 papers) and Angiogenesis and VEGF in Cancer (4 papers). Danielle Murphy collaborates with scholars based in United States, United Kingdom and Italy. Danielle Murphy's co-authors include Sara A. Courtneidge, Michael Dews, William M. Lee, Greg H. Enders, Cinzia Sevignani, Emma E. Furth, Duonan Yu, Erik A. Wentzel, Andrei Thomas‐Tikhonenko and Joshua T. Mendell and has published in prestigious journals such as Nature Medicine, Nature Genetics and Journal of Clinical Oncology.

In The Last Decade

Danielle Murphy

23 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster

2006 851 citations Michael Dews, Duonan Yu et al. Nature Genetics profile →
The 'ins' and 'outs' of podosomes and invadopodia: characteristics, formation and function

2011 821 citations Danielle Murphy, Sara A. Courtneidge Nature Reviews Molecular Cell Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Danielle Murphy United States	16	1.5k	1.0k	544	544	351	23	2.5k
Danfang Zhang China	30	1.7k 1.2×	1.1k 1.0×	861 1.6×	245 0.5×	282 0.8×	65	2.4k
Qunsheng Ji China	25	1.5k 1.0×	560 0.5×	686 1.3×	224 0.4×	538 1.5×	50	2.5k
Mohanraj Dhanabal United States	20	2.1k 1.4×	1.3k 1.3×	537 1.0×	228 0.4×	268 0.8×	28	3.0k
Nicolas Skuli United States	28	1.6k 1.1×	1.3k 1.2×	444 0.8×	298 0.5×	278 0.8×	45	2.6k
Hira Lal Goel United States	29	2.4k 1.6×	855 0.8×	1.1k 2.1×	632 1.2×	551 1.6×	54	3.6k
Corinne Reimer United States	23	1.4k 1.0×	441 0.4×	456 0.8×	460 0.8×	190 0.5×	52	2.1k
Baocun Sun China	38	2.1k 1.4×	1.3k 1.3×	974 1.8×	197 0.4×	294 0.8×	64	2.9k
Aleksandra Franovic United States	18	1.3k 0.8×	744 0.7×	600 1.1×	289 0.5×	336 1.0×	38	2.0k
Roya Navab Canada	25	1.1k 0.7×	638 0.6×	694 1.3×	237 0.4×	270 0.8×	46	2.0k
Kiyoko Yoshioka Japan	23	1.6k 1.1×	339 0.3×	693 1.3×	626 1.2×	313 0.9×	38	2.4k

Countries citing papers authored by Danielle Murphy

Since Specialization

Citations

This map shows the geographic impact of Danielle Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danielle Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danielle Murphy more than expected).

Fields of papers citing papers by Danielle Murphy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danielle Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danielle Murphy. The network helps show where Danielle Murphy may publish in the future.

Co-authorship network of co-authors of Danielle Murphy

This figure shows the co-authorship network connecting the top 25 collaborators of Danielle Murphy. A scholar is included among the top collaborators of Danielle Murphy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danielle Murphy. Danielle Murphy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kopetz, Scott, Danielle Murphy, Jie Pu, et al.. (2024). Molecular profiling of BRAF-V600E-mutant metastatic colorectal cancer in the phase 3 BEACON CRC trial. Nature Medicine. 30(11). 3261–3271. 30 indexed citations

Kopetz, Scott, Danielle Murphy, Jie Pu, et al.. (2022). 316O Genomic mechanisms of acquired resistance of patients (pts) with BRAF V600E-mutant (mt) metastatic colorectal cancer (mCRC) treated in the BEACON study. Annals of Oncology. 33. S681–S682. 14 indexed citations

Kopetz, Scott, Danielle Murphy, Jie Pu, et al.. (2022). Evaluation of baseline BRAF V600E mutation in circulating tumor DNA and efficacy response from the BEACON study.. Journal of Clinical Oncology. 40(4_suppl). 162–162. 16 indexed citations

Camidge, D. Ross, Gregory A. Otterson, Jeffrey W. Clark, et al.. (2021). Crizotinib in Patients With MET-Amplified NSCLC. Journal of Thoracic Oncology. 16(6). 1017–1029. 109 indexed citations

Michaelson, M. Dror, Shilpa Gupta, Neeraj Agarwal, et al.. (2019). A Phase Ib Study of Axitinib in Combination with Crizotinib in Patients with Metastatic Renal Cell Cancer or Other Advanced Solid Tumors. The Oncologist. 24(9). 1151–e817. 6 indexed citations

Drilon, Alexander, Jennifer Clark, Jonathan M. Weiss, et al.. (2018). Updated Antitumor Activity of Crizotinib in Patients with MET Exon 14-Altered Advanced Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 13(10). 6 indexed citations

Drilon, Alexander, Jeffrey W. Clark, Jared Weiss, et al.. (2018). OA12.02 Updated Antitumor Activity of Crizotinib in Patients with MET Exon 14-Altered Advanced Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 13(10). S348–S348. 24 indexed citations

Camidge, D. Ross, Gregory A. Otterson, Jeffrey W. Clark, et al.. (2018). Crizotinib in patients (pts) with MET-amplified non-small cell lung cancer (NSCLC): Updated safety and efficacy findings from a phase 1 trial.. Journal of Clinical Oncology. 36(15_suppl). 9062–9062. 63 indexed citations

Milione, Massimo, Elena Ardini, Jason Christiansen, et al.. (2017). Identification and characterization of a novel SCYL3-NTRK1 rearrangement in a colorectal cancer patient. Oncotarget. 8(33). 55353–55360. 28 indexed citations

10.

Ge, Wei, Roopal Patel, C J Walsh, et al.. (2016). Entrectinib, a highly potent pan-Trk, ROS1, and ALK inhibitor, has broad-spectrum, histology-agnostic anti-tumor activity in molecularly defined cancers. European Journal of Cancer. 69. S33–S33. 4 indexed citations

11.

Murphy, Danielle, Heather A. Ely, Robert Shoemaker, et al.. (2016). Detecting Gene Rearrangements in Patient Populations Through a 2-Step Diagnostic Test Comprised of Rapid IHC Enrichment Followed by Sensitive Next-Generation Sequencing. Applied immunohistochemistry & molecular morphology. 25(7). 513–523. 66 indexed citations

12.

Li, Gang, Seung Tae Kim, Kyoung‐Mee Kim, et al.. (2015). Abstract A173: Potent anti-tumor activity of entrectinib in patient-derived models harboring oncogenic gene rearrangements of NTRKs. Molecular Cancer Therapeutics. 14(12_Supplement_2). A173–A173. 1 indexed citations

13.

Murphy, Danielle, Paul A. Bromann, Jeff H. Tsai, et al.. (2012). Correction: A Src-Tks5 Pathway Is Required for Neural Crest Cell Migration during Embryonic Development. PLoS ONE. 7(8). 3 indexed citations

14.

Murphy, Danielle & Sara A. Courtneidge. (2011). The 'ins' and 'outs' of podosomes and invadopodia: characteristics, formation and function. Nature Reviews Molecular Cell Biology. 12(7). 413–426. 821 indexed citations breakdown →

15.

Murphy, Danielle, Begoña Díaz, Paul A. Bromann, et al.. (2011). A Src-Tks5 Pathway Is Required for Neural Crest Cell Migration during Embryonic Development. PLoS ONE. 6(7). e22499–e22499. 74 indexed citations

16.

Lassoued, Wiem, Danielle Murphy, Jeff H. Tsai, et al.. (2010). Effect of VEGF and VEGF Trap on vascular endothelial cell signaling in tumors. Cancer Biology & Therapy. 10(12). 1326–1333. 38 indexed citations

17.

Chen, Shaohua, Danielle Murphy, Wiem Lassoued, et al.. (2008). Activated STAT3 is a mediator and biomarker of VEGF endothelial activation. Cancer Biology & Therapy. 7(12). 1994–2003. 115 indexed citations

18.

Atluri, Pavan, George P. Liao, Vivian Hsu, et al.. (2006). Neovasculogenic Therapy to Augment Perfusion and Preserve Viability in Ischemic Cardiomyopathy. The Annals of Thoracic Surgery. 81(5). 1728–1736. 29 indexed citations

19.

Dews, Michael, Duonan Yu, Danielle Murphy, et al.. (2006). Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nature Genetics. 38(9). 1060–1065. 851 indexed citations breakdown →

20.

Murphy, Danielle, Sosina Makonnen, Wiem Lassoued, et al.. (2006). Inhibition of Tumor Endothelial ERK Activation, Angiogenesis, and Tumor Growth by Sorafenib (BAY43-9006). American Journal Of Pathology. 169(5). 1875–1885. 133 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact